MDXG

MIMEDX GROUP, INC. · Healthcare · Market cap $666.1M

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$432K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Latest filing

Jul 7, 2026

Maersk-Moller Kimberly

MIMEDX GROUP, INC. (MDXG) has 19 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 7, 2026.

Inside the rolling window, 1 insider at MIMEDX GROUP, INC. reported no open-market purchases and 1 open-market sale totaling $432K. The most recent open-market filing is a sale of 58,300 shares by Chief Commercial Officer Maersk-Moller Kimberly, dated Nov 6, 2025, worth $432K.

  • Industry:Biotechnology
  • CEO:Joseph H. Capper
  • Employees:808
  • HQ:Marietta, GA, US
  • IPO:2008-02-12
Source
Sale$432KNov 10SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does MDXG have?

MIMEDX GROUP, INC. (MDXG) has 19 SEC Form 4 filings (22 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jul 7, 2026.

When was the most recent SEC Form 4 filing for MDXG?

The most recent Form 4 filing for MDXG on Tracefour is dated Jul 7, 2026.

What is the total insider buy and sell value at MDXG in the current window?

Inside the rolling window, insiders at MDXG bought $0 and sold $432K based on SEC Form 4 filings.

Can I get alerts for MDXG insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MIMEDX GROUP, INC. (MDXG). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

MIMEDX GROUP, INC. is in the Healthcare sector.